AbelZeta Pharma - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAbelZeta Pharma
AbelZeta Pharma logo

AbelZeta Pharma

0 followers

CBMG

Performance

About AbelZeta Pharma

AbelZeta Pharma is a global clinical-stage biopharmaceutical company focused on discovering and developing T cell–based therapeutics to treat cancer and inflammatory and immunological diseases. The company emphasizes its proprietary platforms for adoptive cell therapy, including CAR-T and tumor-infiltrating lymphocytes (TIL), targeting hematologic malignancies and solid tumors. Its research and development operates globally, with emphasis on advancing immunotherapies from pipeline through clinical trials to address oncology and immune-mediated conditions.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

Rockville, United States

Founded

2009

Employees

51 - 200

Status

Public

Website

https://abelzeta.com